RELATED CONTENT
NEWS
- Japan Iressa side-effect ruling favours AstraZeneca
- Mirabegron approved in first market as Gardasil and Rotarix also get formal Japanese nod
- NICE drug wars: Tarceva vs Iressa, Revlimid vs IFN alpha, Botox vs SoC, and others
- Roche convinces NICE to add 'incremental' Tarceva as NSCLC treatment option
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

